Aker BioMarine Logo

Aker BioMarine

ISIN

NO0010886625

Ticker

AKBM

Sector

Health Care

Sub-Industry

Biotechnology

Country

Norway

Year Founded

2006

About Aker BioMarine

Company Description

Aker BioMarine was created because of our strong belief in the positive health effects of krill. More than a decade later, our business continues to grow because we take care of the ecosystem we harvest in. To us, it makes no sense to take something out of the ocean to improve our health, if it simultaneously compromises the health of the ocean. Ensuring the well-being of the krill biomass and contributing towards a thriving Antarctic ecosystem are among our core priorities.

The unique phospholipid-bound omega-3s in krill can help reduce the risk of several lifestyle diseases, including heart and brain-related issues. Aker BioMarine has taken on a global challenge to raise awareness about the importance of omega-3s. In 2020, 1,6 billion doses of Superba Krill were sold worldwide, improving the health of millions of people.

Served Area

Worldwide

Headquarters

Oksenøyveien 10
1327, Lysaker
Norway

Capital Markets Information

ISIN

NO0010886625

LEI

549300MU8WPXD29E3I11

Sub-Industry

Biotechnology

Listed Stock Exchange

Oslo Børs

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.